person · Reporting owner

Drake Scott William

Disclosed activity across 5 companies

Tapewire entity: 111239
SEC CIK: 0001527909

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
AtriCure, Inc.ATRC · Entity 2704	Director	May 07, 2021	May 11, 2021
Paragon 28, Inc.FNA · Entity 80621	Director	May 18, 2022	May 20, 2022
ViewRay, Inc.VRAY · Entity 111118	Director	July 18, 2023	July 20, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AtriCure, Inc.

Report date May 07, 2021 · Filed May 11, 2021

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	41,036	Ending reported balance After 2021-05-10 transaction · row 4 4 source rows · reconciled sequence Row 1 · 2021-05-07 · Exercise / conversion · Acquired 38,641 · Balance 79,677 Row 2 · 2021-05-07 · Sale · Disposed 38,641 · Balance 41,036 F1: This transaction was executed in multiple trades at prices ranging from $77.52 to $79.13 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 3 · 2021-05-10 · Exercise / conversion · Acquired 4,631 · Balance 45,667 Row 4 · 2021-05-10 · Sale · Disposed 4,631 · Balance 41,036 F2: This transaction was executed in multiple trades at prices ranging from $76.00 to $76.84 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.98 · Expires 2023-09-03	Direct	11,359	Reported balance After 2021-05-07 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2021-05-07 · Exercise / conversion · Disposed 38,641 · Balance 11,359 F3: These options were granted on September 3, 2013. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.98 · Expires 2023-09-03	Direct	6,728	Reported balance After 2021-05-10 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2021-05-10 · Exercise / conversion · Disposed 4,631 · Balance 6,728 F3: These options were granted on September 3, 2013. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.

Filing footnotes · ownership attribution and instrument terms

F1: This transaction was executed in multiple trades at prices ranging from $77.52 to $79.13 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: This transaction was executed in multiple trades at prices ranging from $76.00 to $76.84 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: These options were granted on September 3, 2013. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.

Paragon 28, Inc.

Report date May 18, 2022 · Filed May 20, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	15,949	Reported balance After 2022-05-18 transaction · row 1 1 source row Row 1 · 2022-05-18 · Grant · Acquired 8,918 · Balance 15,949 F1: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) the first anniversary of grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the Reporting Person's continued service to the issuer.

Filing footnotes · ownership attribution and instrument terms

F1: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) the first anniversary of grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the Reporting Person's continued service to the issuer.

ViewRay, Inc.

Report date July 18, 2023 · Filed July 20, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,591,615	Reported balance After 2023-07-18 transaction · row 1 1 source row Row 1 · 2023-07-18 · Sale · Disposed 2,408,747 · Balance 1,591,615 F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.059 to $0.067, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range stated.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.059 to $0.067, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range stated.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

SPECTRANETICS CORP

Report date August 09, 2017 · Filed August 11, 2017

Section 16 reporting ended · disclosed 2017-08-11. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
SPNC Common StockSEC Table I · non-derivative	Direct	Reported balance After 2017-08-09 transaction · row 1 1 source row Row 1 · 2017-08-09 · Disposition to issuer · Disposed 269,027 · Balance 0 F1: Per the terms of the Agreement and Plan of Merger, dated as of June 27, 2017, among the Company, Philips Holding USA Inc., a Delaware corporation, and HealthTech Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock other than the shares described in Note 2 below was validly tendered for $38.50 per share in cash, without interest and less any required withholding taxes. F2: Includes 45,453 shares of Company common stock underlying performance stock units that were subject solely to service-based vesting conditions immediately prior to the Effective Time (as defined in the Merger Agreement) and that, pursuant to their terms upon consummation of the Merger Agreement, were treated as restricted stock units and were cancelled at the Effective Time and converted into the right to receive $38.50 per share in cash, without interest and less any required withholding taxes.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.63 · Expires 2021-08-10	Direct	Reported balance After 2017-08-09 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2017-08-09 · Disposition to issuer · Disposed 200,707 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.87 · Expires 2022-05-31	Direct	Reported balance After 2017-08-09 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2017-08-09 · Disposition to issuer · Disposed 100,000 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.44 · Expires 2023-07-10	Direct	Reported balance After 2017-08-09 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2017-08-09 · Disposition to issuer · Disposed 99,403 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.05 · Expires 2026-01-08	Direct	Reported balance After 2017-08-09 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2017-08-09 · Disposition to issuer · Disposed 100,675 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2017-08-09 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2017-08-09 · Disposition to issuer · Disposed 8,600 · Balance 0 F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2017-08-09 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2017-08-09 · Disposition to issuer · Disposed 1,936 · Balance 0 F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2017-08-09 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2017-08-09 · Disposition to issuer · Disposed 14,060 · Balance 0 F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2017-08-09 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2017-08-09 · Disposition to issuer · Disposed 16,611 · Balance 0 F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2017-08-09 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2017-08-09 · Disposition to issuer · Disposed 64,706 · Balance 0 F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes.
Performance Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2017-08-09 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2017-08-09 · Disposition to issuer · Disposed 206,498 · Balance 0 F5: Per the terms of the Merger Agreement, each performance stock unit award (other than performance stock units described in Note 2 above) that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash equal to the product of (i) (A) for performance stock units granted in 2016, the number of shares of Company common stock subject to such Company performance stock unit (assuming that any applicable performance conditions were deemed to be achieved at 150% of the target performance level), and (B) for performance stock units granted in 2017, the number of shares of Company common stock subject to such performance stock units (assuming that any applicable performance conditions were deemed to be achieved at the target performance level) and (ii) $38.50, without interest and less any required withholding taxes.
Performance Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2017-08-09 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2017-08-09 · Disposition to issuer · Disposed 43,138 · Balance 0 F5: Per the terms of the Merger Agreement, each performance stock unit award (other than performance stock units described in Note 2 above) that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash equal to the product of (i) (A) for performance stock units granted in 2016, the number of shares of Company common stock subject to such Company performance stock unit (assuming that any applicable performance conditions were deemed to be achieved at 150% of the target performance level), and (B) for performance stock units granted in 2017, the number of shares of Company common stock subject to such performance stock units (assuming that any applicable performance conditions were deemed to be achieved at the target performance level) and (ii) $38.50, without interest and less any required withholding taxes.

Filing footnotes · ownership attribution and instrument terms

F1: Per the terms of the Agreement and Plan of Merger, dated as of June 27, 2017, among the Company, Philips Holding USA Inc., a Delaware corporation, and HealthTech Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock other than the shares described in Note 2 below was validly tendered for $38.50 per share in cash, without interest and less any required withholding taxes.

F2: Includes 45,453 shares of Company common stock underlying performance stock units that were subject solely to service-based vesting conditions immediately prior to the Effective Time (as defined in the Merger Agreement) and that, pursuant to their terms upon consummation of the Merger Agreement, were treated as restricted stock units and were cancelled at the Effective Time and converted into the right to receive $38.50 per share in cash, without interest and less any required withholding taxes.

F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes.

F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes.

F5: Per the terms of the Merger Agreement, each performance stock unit award (other than performance stock units described in Note 2 above) that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash equal to the product of (i) (A) for performance stock units granted in 2016, the number of shares of Company common stock subject to such Company performance stock unit (assuming that any applicable performance conditions were deemed to be achieved at 150% of the target performance level), and (B) for performance stock units granted in 2017, the number of shares of Company common stock subject to such performance stock units (assuming that any applicable performance conditions were deemed to be achieved at the target performance level) and (ii) $38.50, without interest and less any required withholding taxes.

Zayo Group Holdings, Inc.

Report date March 09, 2020 · Filed March 09, 2020

Section 16 reporting ended · disclosed 2020-03-09. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2020-03-09 transaction · row 1 1 source row Row 1 · 2020-03-09 · Disposition to issuer · Disposed 10,430 · Balance 0 F1: On May 8, 2019, Zayo Group Holdings, Inc. (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") by and among Front Range TopCo, Inc. ("Parent") and Front Range BidCo, Inc. ("Merger Sub"). On March 9, 2020, Merger Sub merged with any into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation and becoming a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, each share of Company common stock was converted into the right to receive an amount in cash equal to $35 (the "Merger Consideration"), without interest and not including any required withholding of taxes.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2020-03-09 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2020-03-09 · Disposition to issuer · Disposed 1,911 · Balance 0 F2: Each unvested Part C RSU held by the Reporting Person was converted into the right to receive the Merger Consideration for such RSU, to be paid in full to the Reporting Person on March 31, 2020, without interest and not including any required withholding of taxes. F3: On January 6, 2020, the Reporting Person was granted the reported number of Part C RSUs that were unvested as of the closing of the Merger. Each such RSU held by the Reporting Person was converted into the right to receive the Merger Consideration for each such RSU, to be paid in full to the Reporting Person on March 31, 2020, without interest and not including any required withholding of taxes.

Filing footnotes · ownership attribution and instrument terms

F1: On May 8, 2019, Zayo Group Holdings, Inc. (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") by and among Front Range TopCo, Inc. ("Parent") and Front Range BidCo, Inc. ("Merger Sub"). On March 9, 2020, Merger Sub merged with any into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation and becoming a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, each share of Company common stock was converted into the right to receive an amount in cash equal to $35 (the "Merger Consideration"), without interest and not including any required withholding of taxes.

F2: Each unvested Part C RSU held by the Reporting Person was converted into the right to receive the Merger Consideration for such RSU, to be paid in full to the Reporting Person on March 31, 2020, without interest and not including any required withholding of taxes.

F3: On January 6, 2020, the Reporting Person was granted the reported number of Part C RSUs that were unvested as of the closing of the Merger. Each such RSU held by the Reporting Person was converted into the right to receive the Merger Consideration for each such RSU, to be paid in full to the Reporting Person on March 31, 2020, without interest and not including any required withholding of taxes.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
October 24, 2019 Filed Oct 28, 2019 16:55 UTC	ViewRay, Inc. VRAY · Entity 111118	GrantCommon Stock	1,250,000	$0.00	$0.00	Disclosure SEC source: 0001209191-19-054259 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,606,983 F1 · kind: A total of one-third of the shares subject to this grant become vested on each of the first three anniversaries of October 24, 2019, subject to the Reporting Person remaining a service provider through each such vesting date. F2 · balance_after: Includes 2,415,723 shares granted as RSUs. As of the transaction date, 215,676 of the RSUs have vested. Read SEC document
October 24, 2019 Filed Nov 19, 2019 19:01 UTC Amendment	ViewRay, Inc. VRAY · Entity 111118	OtherCommon Stock	744,091	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-057342 · doc4a.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,862,892 F1 · kind: Represents the cancellation of RSUs where no value was received for the cancellation. F1 · price: Represents the cancellation of RSUs where no value was received for the cancellation. F2 · balance_after: Includes 1,671,632 shares granted as RSUs. As of the transaction date and the amended filing date of this Form 4/A, 215,676 of the RSUs have vested. Read SEC document
October 04, 2019 Filed Oct 7, 2019 16:55 UTC	Zayo Group Holdings, Inc. ZAYO · Entity 150849	GrantRestricted Stock Units · Derivative	1,947	$0.00	$0.00	Disclosure SEC source: 0001209191-19-052698 · doc4.xml · derivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,947 Underlying: Common Stock · 1,947 shares Expires not disclosed F1 · derivative.exercise_price: Each Part C restricted stock unit represents a contingent right to receive one share of Zayo Group Holdings, Inc. common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on December 31, 2019. F2 · derivative.expiration_date: The restricted stock units vest in full on December 31, 2019. Read SEC document
September 30, 2019 Filed Oct 2, 2019 18:02 UTC	Zayo Group Holdings, Inc. ZAYO · Entity 150849	Exercise / conversionRestricted Stock units · Derivative	2,004	$0.00	$0.00	Disclosure SEC source: 0001209191-19-051892 · doc4.xml · derivative · entry 2 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,004 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Part C restricted stock unit converted into one share of Zayo Group Holdings, Inc. common stock. F2 · derivative.exercise_date: On July 5, 2019 the reporting person was granted Part C restricted stock units, which vested in full on September 30, 2019. F2 · derivative.expiration_date: On July 5, 2019 the reporting person was granted Part C restricted stock units, which vested in full on September 30, 2019. Read SEC document
September 30, 2019 Filed Oct 2, 2019 18:02 UTC	Zayo Group Holdings, Inc. ZAYO · Entity 150849	Exercise / conversionCommon Stock	2,004	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-051892 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,483 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Part C restricted stock unit converted into one share of Zayo Group Holdings, Inc. common stock. Read SEC document
August 13, 2019 Filed Aug 13, 2019 17:21 UTC	ViewRay, Inc. VRAY · Entity 111118	PurchaseCommon Stock	131,260	$3.81	$500,048.10	Disclosure SEC source: 0001209191-19-045783 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,356,983 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.53 to $3.93, inclusive. The reporting person undertakes to provide to ViewRay, Inc., any security holder of ViewRay, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · balance_after: Includes 1,165,723 shares granted as RSUs. As of the transaction date, 215,676 of the RSUs have vested. Read SEC document
July 22, 2019 Filed Aug 7, 2019 20:37 UTC	ViewRay, Inc. VRAY · Entity 111118	Tax withholdingCommon Stock	169,324	$9.49	$1,606,884.76	Disclosure SEC source: 0001209191-19-045047 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,225,723 F1 · shares: In connection with the vesting of shares of RSUs, ViewRay, Inc. (the "Issuer") withheld vested shares to satisfy tax withholding obligations. The number of vested shares withheld was based on the closing price per share on July 22, 2019. The withholding of vested shares pursuant to this award was approved by the Compensation Committee of the Board of Directors of the Issuer, and the number of shares indicated in this Form 4 was acquired as treasury stock by the Issuer. F2 · balance_after: Includes 1,165,723 shares granted as RSUs. As of the transaction date, 215,676 of the RSUs have vested. Read SEC document
July 05, 2019 Filed Jul 8, 2019 18:00 UTC	Zayo Group Holdings, Inc. ZAYO · Entity 150849	GrantRestricted Stock Units · Derivative	2,004	$0.00	$0.00	Disclosure SEC source: 0001209191-19-041471 · doc4.xml · derivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,004 Underlying: Common Stock · 2,004 shares Expires not disclosed F1 · derivative.exercise_price: Each Part C restricted stock unit represents a contingent right to receive one share of Zayo Group Holdings, Inc. common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on September 30, 2019. F2 · derivative.expiration_date: The restricted stock units vest in full on September 30, 2019. Read SEC document
June 28, 2019 Filed Jul 1, 2019 18:47 UTC	Zayo Group Holdings, Inc. ZAYO · Entity 150849	Exercise / conversionRestricted Stock units · Derivative	2,334	$0.00	$0.00	Disclosure SEC source: 0001209191-19-039854 · doc4.xml · derivative · entry 2 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Part C restricted stock unit converted into one share of Zayo Group Holdings, Inc. common stock. F2 · derivative.exercise_date: On April 5, 2019 the reporting person was granted Part C restricted stock units, which vested in full on June 28, 2019. F2 · derivative.expiration_date: On April 5, 2019 the reporting person was granted Part C restricted stock units, which vested in full on June 28, 2019. Read SEC document
June 28, 2019 Filed Jul 1, 2019 18:47 UTC	Zayo Group Holdings, Inc. ZAYO · Entity 150849	Exercise / conversionCommon Stock	2,334	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-039854 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,479 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Part C restricted stock unit converted into one share of Zayo Group Holdings, Inc. common stock. Read SEC document
May 22, 2019 Filed May 24, 2019 12:48 UTC	AtriCure, Inc. ATRC · Entity 2704	GrantCommon Stock	4,208	$0.00	$0.00	Disclosure SEC source: 0001209191-19-032577 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,234 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document
April 05, 2019 Filed Apr 9, 2019 18:26 UTC	Zayo Group Holdings, Inc. ZAYO · Entity 150849	GrantRestricted Stock Units · Derivative	2,334	$0.00	$0.00	Disclosure SEC source: 0001209191-19-024154 · doc4.xml · derivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,334 Underlying: Common Stock · 2,334 shares Expires not disclosed F1 · derivative.exercise_price: Each Part C restricted stock unit represents a contingent right to receive one share of Zayo Group Holdings, Inc. common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on June 30, 2019. F2 · derivative.expiration_date: The restricted stock units vest in full on June 30, 2019. Read SEC document
March 29, 2019 Filed Apr 2, 2019 16:17 UTC	Zayo Group Holdings, Inc. ZAYO · Entity 150849	Exercise / conversionRestricted Stock units · Derivative	2,990	$0.00	$0.00	Disclosure SEC source: 0001209191-19-022421 · doc4.xml · derivative · entry 2 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,990 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Part C restricted stock unit converted into one share of Zayo Group Holdings, Inc. common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on March 31, 2019. F2 · derivative.expiration_date: The restricted stock units vest in full on March 31, 2019. Read SEC document
March 01, 2019 Filed Mar 5, 2019 16:42 UTC	ViewRay, Inc. VRAY · Entity 111118	GrantStock Option (right to buy) · Derivative	314,044	$0.00 Strike: $8.47	$0.00	Disclosure SEC source: 0001209191-19-016583 · doc4.xml · derivative · entry 2 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,044 Underlying: Common Stock · 314,044 shares Expires 2029-03-01 F1 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest and become exercisable on each month after March 1, 2019 (the "Grant Date"), such that 100% of the shares subject to the option will be vested on the fourth anniversary of the Grant Date, subject to the reporting person remaining a service provider through each such vesting date. Read SEC document
March 01, 2019 Filed Mar 5, 2019 16:42 UTC	ViewRay, Inc. VRAY · Entity 111118	GrantCommon Stock	180,047	$0.00	$0.00	Disclosure SEC source: 0001209191-19-016583 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,395,047 Read SEC document
January 02, 2019 Filed Jan 3, 2019 19:59 UTC	Zayo Group Holdings, Inc. ZAYO · Entity 150849	GrantRestricted Stock units · Derivative	2,990	$0.00	$0.00	Disclosure SEC source: 0001209191-19-001492 · doc4.xml · derivative · entry 3 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,990 Underlying: Common Stock · 2,990 shares Expires not disclosed F1 · derivative.exercise_price: Each Part C restricted stock unit converted into one share of Zayo Group Holdings, Inc. common stock. F3 · derivative.exercise_date: The restricted stock units vest in full on March 31, 2019. F3 · derivative.expiration_date: The restricted stock units vest in full on March 31, 2019. Read SEC document
December 31, 2018 Filed Jan 3, 2019 19:59 UTC	Zayo Group Holdings, Inc. ZAYO · Entity 150849	Exercise / conversionRestricted Stock units · Derivative	1,155	$0.00	$0.00	Disclosure SEC source: 0001209191-19-001492 · doc4.xml · derivative · entry 2 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,155 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Part C restricted stock unit converted into one share of Zayo Group Holdings, Inc. common stock. F2 · derivative.exercise_date: On November 8, 2018 the reporting person was granted Part C restricted stock units, which vested in full on December 31, 2018. F2 · derivative.expiration_date: On November 8, 2018 the reporting person was granted Part C restricted stock units, which vested in full on December 31, 2018. Read SEC document
December 31, 2018 Filed Jan 3, 2019 19:59 UTC	Zayo Group Holdings, Inc. ZAYO · Entity 150849	Exercise / conversionCommon Stock	1,155	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-001492 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Part C restricted stock unit converted into one share of Zayo Group Holdings, Inc. common stock. Read SEC document
November 13, 2018 Filed Nov 13, 2018 19:06 UTC	ViewRay, Inc. VRAY · Entity 111118	PurchaseCommon Stock	60,000	$6.47	$388,200.00	Disclosure SEC source: 0000950103-18-013356 · dp98357_4-drake.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,215,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.28 to $6.63, inclusive. The reporting person undertakes to provide to ViewRay, Inc., any security holder of ViewRay, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document
November 08, 2018 Filed Nov 9, 2018 15:20 UTC	Zayo Group Holdings, Inc. ZAYO · Entity 150849	GrantRestricted Stock Units · Derivative	1,155	$0.00	$0.00	Disclosure SEC source: 0001209191-18-057923 · doc4.xml · derivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,155 Underlying: Common Stock · 1,155 shares Expires not disclosed F1 · derivative.exercise_price: Each Part C restricted stock unit represents a contingent right to receive one share of Zayo Group Holdings, Inc. common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on December 31, 2018. F2 · derivative.expiration_date: The restricted stock units vest in full on December 31, 2018. Read SEC document
July 22, 2018 Filed Jul 24, 2018 20:01 UTC	ViewRay, Inc. VRAY · Entity 111118	GrantStock Option (right to buy) · Derivative	1,925,000	$0.00 Strike: $9.66	$0.00	Disclosure SEC source: 0000950103-18-008821 · ownership.xml · derivative · entry 2 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,925,000 Underlying: Common Stock · 1,925,000 shares Expires 2028-07-22 F2 · derivative.exercise_date: The shares subject to this stock option are subject to service-based vesting requirements. 25% of the shares subject to the option shall vest and become exercisable on the first anniversary of July 22, 2018 (the "Vesting Commencement Date"), and thereafter, the remainder of the reported securities vest in equal monthly increments over the following 36 months, such that 100% of the reported securities will be vested as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person remaining a service provider through each such vesting date. Read SEC document
July 22, 2018 Filed Jul 24, 2018 20:01 UTC	ViewRay, Inc. VRAY · Entity 111118	GrantCommon Stock	1,155,000	$0.00	$0.00	Disclosure SEC source: 0000950103-18-008821 · ownership.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,155,000 F1 · kind: A total of one-third of the shares subject to this grant become vested on each of the first three anniversaries of July 22, 2018, subject to the Reporting Person remaining a service provider through each such vesting date. Read SEC document
May 22, 2018 Filed May 24, 2018 20:31 UTC	AtriCure, Inc. ATRC · Entity 2704	GrantCommon Stock	5,221	$0.00	$0.00	Disclosure SEC source: 0001209191-18-032982 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,026 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document
March 29, 2018 Filed Apr 2, 2019 16:17 UTC	Zayo Group Holdings, Inc. ZAYO · Entity 150849	Exercise / conversionCommon Stock	2,990	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-022421 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Part C restricted stock unit converted into one share of Zayo Group Holdings, Inc. common stock. Read SEC document
March 01, 2018 Filed Mar 2, 2018 21:38 UTC	AtriCure, Inc. ATRC · Entity 2704	PurchaseCommon Stock	11,000	$17.64	$194,040.00	Disclosure SEC source: 0001209191-18-015689 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,805 F1 · price: This transaction was executed in multiple trades at prices ranging from $17.36 to $17.91 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document
August 09, 2017 Filed Aug 11, 2017 14:36 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Disposition to issuerPerformance Stock Units · Derivative	43,138	$38.50 Strike: $0.00	$1,660,813.00	Disclosure SEC source: 0001179110-17-011367 · edgar.xml · derivative · entry 12 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 43,138 shares Expires not disclosed F5 · derivative.exercise_date: Per the terms of the Merger Agreement, each performance stock unit award (other than performance stock units described in Note 2 above) that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash equal to the product of (i) (A) for performance stock units granted in 2016, the number of shares of Company common stock subject to such Company performance stock unit (assuming that any applicable performance conditions were deemed to be achieved at 150% of the target performance level), and (B) for performance stock units granted in 2017, the number of shares of Company common stock subject to such performance stock units (assuming that any applicable performance conditions were deemed to be achieved at the target performance level) and (ii) $38.50, without interest and less any required withholding taxes. F5 · derivative.expiration_date: Per the terms of the Merger Agreement, each performance stock unit award (other than performance stock units described in Note 2 above) that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash equal to the product of (i) (A) for performance stock units granted in 2016, the number of shares of Company common stock subject to such Company performance stock unit (assuming that any applicable performance conditions were deemed to be achieved at 150% of the target performance level), and (B) for performance stock units granted in 2017, the number of shares of Company common stock subject to such performance stock units (assuming that any applicable performance conditions were deemed to be achieved at the target performance level) and (ii) $38.50, without interest and less any required withholding taxes. Read SEC document
August 09, 2017 Filed Aug 11, 2017 14:36 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Disposition to issuerPerformance Stock Units · Derivative	206,498	$38.50 Strike: $0.00	$7,950,173.00	Disclosure SEC source: 0001179110-17-011367 · edgar.xml · derivative · entry 11 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 206,498 shares Expires not disclosed F5 · derivative.exercise_date: Per the terms of the Merger Agreement, each performance stock unit award (other than performance stock units described in Note 2 above) that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash equal to the product of (i) (A) for performance stock units granted in 2016, the number of shares of Company common stock subject to such Company performance stock unit (assuming that any applicable performance conditions were deemed to be achieved at 150% of the target performance level), and (B) for performance stock units granted in 2017, the number of shares of Company common stock subject to such performance stock units (assuming that any applicable performance conditions were deemed to be achieved at the target performance level) and (ii) $38.50, without interest and less any required withholding taxes. F5 · derivative.expiration_date: Per the terms of the Merger Agreement, each performance stock unit award (other than performance stock units described in Note 2 above) that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash equal to the product of (i) (A) for performance stock units granted in 2016, the number of shares of Company common stock subject to such Company performance stock unit (assuming that any applicable performance conditions were deemed to be achieved at 150% of the target performance level), and (B) for performance stock units granted in 2017, the number of shares of Company common stock subject to such performance stock units (assuming that any applicable performance conditions were deemed to be achieved at the target performance level) and (ii) $38.50, without interest and less any required withholding taxes. Read SEC document
August 09, 2017 Filed Aug 11, 2017 14:36 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Disposition to issuerRestricted Stock Units · Derivative	64,706	$38.50 Strike: $0.00	$2,491,181.00	Disclosure SEC source: 0001179110-17-011367 · edgar.xml · derivative · entry 10 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 64,706 shares Expires not disclosed F4 · derivative.exercise_date: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. F4 · derivative.expiration_date: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. Read SEC document
August 09, 2017 Filed Aug 11, 2017 14:36 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Disposition to issuerRestricted Stock Units · Derivative	16,611	$38.50 Strike: $0.00	$639,523.50	Disclosure SEC source: 0001179110-17-011367 · edgar.xml · derivative · entry 9 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,611 shares Expires not disclosed F4 · derivative.exercise_date: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. F4 · derivative.expiration_date: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. Read SEC document
August 09, 2017 Filed Aug 11, 2017 14:36 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Disposition to issuerRestricted Stock Units · Derivative	14,060	$38.50 Strike: $0.00	$541,310.00	Disclosure SEC source: 0001179110-17-011367 · edgar.xml · derivative · entry 8 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,060 shares Expires not disclosed F4 · derivative.exercise_date: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. F4 · derivative.expiration_date: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. Read SEC document
August 09, 2017 Filed Aug 11, 2017 14:36 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Disposition to issuerRestricted Stock Units · Derivative	1,936	$38.50 Strike: $0.00	$74,536.00	Disclosure SEC source: 0001179110-17-011367 · edgar.xml · derivative · entry 7 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,936 shares Expires not disclosed F4 · derivative.exercise_date: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. F4 · derivative.expiration_date: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. Read SEC document
August 09, 2017 Filed Aug 11, 2017 14:36 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Disposition to issuerRestricted Stock Units · Derivative	8,600	$38.50 Strike: $0.00	$331,100.00	Disclosure SEC source: 0001179110-17-011367 · edgar.xml · derivative · entry 6 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,600 shares Expires not disclosed F4 · derivative.exercise_date: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. F4 · derivative.expiration_date: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. Read SEC document
August 09, 2017 Filed Aug 11, 2017 14:36 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Disposition to issuerStock Option (Right to Buy) · Derivative	100,675	$23.45 Strike: $15.05	$2,360,828.75	Disclosure SEC source: 0001179110-17-011367 · edgar.xml · derivative · entry 5 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,675 shares Expires 2026-01-08 F3 · derivative.exercise_date: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. Read SEC document
August 09, 2017 Filed Aug 11, 2017 14:36 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Disposition to issuerStock Option (Right to Buy) · Derivative	99,403	$20.06 Strike: $18.44	$1,994,024.18	Disclosure SEC source: 0001179110-17-011367 · edgar.xml · derivative · entry 4 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 99,403 shares Expires 2023-07-10 F3 · derivative.exercise_date: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. Read SEC document
August 09, 2017 Filed Aug 11, 2017 14:36 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Disposition to issuerStock Option (Right to Buy) · Derivative	100,000	$28.63 Strike: $9.87	$2,863,000.00	Disclosure SEC source: 0001179110-17-011367 · edgar.xml · derivative · entry 3 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2022-05-31 F3 · derivative.exercise_date: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. Read SEC document
August 09, 2017 Filed Aug 11, 2017 14:36 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Disposition to issuerStock Option (Right to Buy) · Derivative	200,707	$32.87 Strike: $5.63	$6,597,239.09	Disclosure SEC source: 0001179110-17-011367 · edgar.xml · derivative · entry 2 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,707 shares Expires 2021-08-10 F3 · derivative.exercise_date: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. Read SEC document
August 09, 2017 Filed Aug 11, 2017 14:36 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Disposition to issuerSPNC Common Stock	269,027	$38.50	$10,357,539.50	Disclosure SEC source: 0001179110-17-011367 · edgar.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Per the terms of the Agreement and Plan of Merger, dated as of June 27, 2017, among the Company, Philips Holding USA Inc., a Delaware corporation, and HealthTech Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock other than the shares described in Note 2 below was validly tendered for $38.50 per share in cash, without interest and less any required withholding taxes. F2 · shares: Includes 45,453 shares of Company common stock underlying performance stock units that were subject solely to service-based vesting conditions immediately prior to the Effective Time (as defined in the Merger Agreement) and that, pursuant to their terms upon consummation of the Merger Agreement, were treated as restricted stock units and were cancelled at the Effective Time and converted into the right to receive $38.50 per share in cash, without interest and less any required withholding taxes. Read SEC document
July 10, 2017 Filed Jul 11, 2017 17:59 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Exercise / conversionSPNC Restricted Stock Unit · Derivative	9,879	$0.00	$0.00	Disclosure SEC source: 0000789132-17-000119 · wf-form4_149981034095200.xml · derivative · entry 3 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: SPNC Common Stock · 9,879 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Spectranetic's common stock. F4 · derivative.exercise_date: Grant Date: 7/10/2013. Restricted Stock Units are on a 4 year 100% vesting schedule; 25% vested on 7/10/2014; 25% vested on 7/10/2015; and 25% vests each calendar year thereafter. 100% fully vested on 7/10/2017. F5 · derivative.expiration_date: Not Applicable Read SEC document
July 10, 2017 Filed Jul 11, 2017 17:59 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Tax withholdingSPNC Common Stock	4,601	$38.35	$176,448.35	Disclosure SEC source: 0000789132-17-000119 · wf-form4_149981034095200.xml · nonDerivative · entry 2 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,027 F2 · shares: Shares withheld to satisfy tax withholding obligations. Read SEC document
July 10, 2017 Filed Jul 11, 2017 17:59 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Exercise / conversionSPNC Common Stock	9,879	$0.00	$0.00	Disclosure SEC source: 0000789132-17-000119 · wf-form4_149981034095200.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,628 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted Stock Units granted 7/10/2013; fourth 25% vested 7/10/2017. Read SEC document
June 25, 2017 Filed Jun 27, 2017 17:29 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Exercise / conversionSPNC Restricted Stock Unit · Derivative	8,600	$0.00	$0.00	Disclosure SEC source: 0000789132-17-000113 · wf-form4_149859894793533.xml · derivative · entry 3 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,600 Underlying: SPNC Common Stock · 8,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Spectranetic's common stock. F4 · derivative.exercise_date: Grant Date: 6/25/2014. Restricted Stock Units are on a 4 year 100% vesting schedule; 25% vested on 6/25/2015; 25% vested on 6/25/2016; and 25% vests each calendar year thereafter. 100% fully vested on 6/25/2018. F5 · derivative.expiration_date: Not Applicable Read SEC document
June 25, 2017 Filed Jun 27, 2017 17:29 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Tax withholdingSPNC Common Stock	4,005	$30.90	$123,754.50	Disclosure SEC source: 0000789132-17-000113 · wf-form4_149859894793533.xml · nonDerivative · entry 2 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,749 F2 · shares: Shares withheld to satisfy tax withholding obligations. Read SEC document
June 25, 2017 Filed Jun 27, 2017 17:29 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Exercise / conversionSPNC Common Stock	8,600	$0.00	$0.00	Disclosure SEC source: 0000789132-17-000113 · wf-form4_149859894793533.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted Stock Units granted 6/25/2014; third 25% vested 6/25/2017. Read SEC document
June 11, 2017 Filed Jun 13, 2017 17:31 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Exercise / conversionSPNC Restricted Stock Unit · Derivative	7,031	$0.00	$0.00	Disclosure SEC source: 0000789132-17-000101 · wf-form4_149738944562792.xml · derivative · entry 3 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,060 Underlying: SPNC Common Stock · 7,031 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Spectranetic's common stock. F4 · derivative.exercise_date: Grant Date: 6/11/2015. Restricted Stock Units are on a 4 year 100% vesting schedule; 25% vested on 6/11/2016; and 25% vests each calendar year thereafter. 100% fully vested on 6/11/2019. F5 · derivative.expiration_date: Not Applicable Read SEC document
June 11, 2017 Filed Jun 13, 2017 17:31 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Tax withholdingSPNC Common Stock	3,275	$26.35	$86,296.25	Disclosure SEC source: 0000789132-17-000101 · wf-form4_149738944562792.xml · nonDerivative · entry 2 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,154 F2 · shares: Shares withheld to satisfy tax withholding obligations. Read SEC document
June 11, 2017 Filed Jun 13, 2017 17:31 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Exercise / conversionSPNC Common Stock	7,031	$0.00	$0.00	Disclosure SEC source: 0000789132-17-000101 · wf-form4_149738944562792.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted Stock Units granted 6/11/2015; second 25% vested 6/11/2017. Read SEC document
May 24, 2017 Filed May 25, 2017 20:29 UTC	AtriCure, Inc. ATRC · Entity 2704	GrantCommon Stock	5,805	$0.00	$0.00	Disclosure SEC source: 0001209191-17-035388 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,805 F1 · security: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. Read SEC document
February 22, 2017 Filed Feb 24, 2017 17:05 UTC	SPECTRANETICS CORP SPNC · Entity 173862	Tax withholdingSPNC Common Stock	63,516	$24.50	$1,556,142.00	Disclosure SEC source: 0000789132-17-000048 · wf-form4_148797392828029.xml · nonDerivative · entry 2 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,398 F2 · shares: Shares withheld to satisfy tax withholding obligations on 136,359 shares issued in settlement of vested PSUs on February 22, 2017. F3 · balance_after: This number includes 45,453 earned PSUs that are scheduled to vest and be settled in an equal number of Company shares as described above. Read SEC document
February 22, 2017 Filed Feb 24, 2017 17:05 UTC	SPECTRANETICS CORP SPNC · Entity 173862	GrantSPNC Common Stock	181,812	$0.00	$0.00	Disclosure SEC source: 0000789132-17-000048 · wf-form4_148797392828029.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,914 F1 · shares: On June 25, 2014, the Reporting Person was awarded 187,435 target performance stock units ("PSUs") granted for the 2014-2016 performance period. Each earned and vested PSU is payable in one share of the Company's common stock. The Reporting Person earned 181,812 of the PSUs based upon the Company's achievement of certain performance goals during the performance period. Of the 181,812 earned PSUs, 75% vested and were settled in an equal number of shares of the Company's common stock on February 22, 2017, and 25% will vest and be settled in shares on December 31, 2017. Read SEC document
January 13, 2017 Filed Jan 18, 2017 17:30 UTC	SPECTRANETICS CORP SPNC · Entity 173862	GrantSPNC Restricted Stock Unit · Derivative	64,706	$0.00	$0.00	Disclosure SEC source: 0000789132-17-000020 · wf-form4_148477864190493.xml · derivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,706 Underlying: Common Stock · 64,706 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Spectranetics common stock. F2 · derivative.exercise_date: Grant Date: 1/13/2017. RSUs vest 25% on each of the first four anniversaries of the grant date. RSUs are 100% vested on 1/13/2021. F2 · derivative.expiration_date: Grant Date: 1/13/2017. RSUs vest 25% on each of the first four anniversaries of the grant date. RSUs are 100% vested on 1/13/2021. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.